Commonwealth Equity Services »

Esperion Therapeutics shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $38k 14k 2.67

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Value Etf (VTV)

View all positions for Commonwealth Equity Services

Top funds holding Esperion Therapeutics

OrbiMed Advisors
Bellevue Group
Daniel D. Thurber
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Woodline Partners
Millennium Management
D. E. Shaw & Co
Bank of America Corporation
Two Seas Capital
Two Sigma Investments
Meditor
Citadel Advisors
Two Sigma Advisers
Goldman Sachs Group

View all funds holding Esperion Therapeutics